1-4 of 4
Wenjuan Wu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine

Free
Shripad V. Bhagwat, William T. McMillen, Shufen Cai, Baohui Zhao, Matthew Whitesell, Weihua Shen, Lisa Kindler, Robert S. Flack, Wenjuan Wu, Bryan Anderson, Yan Zhai, Xiu-Juan Yuan, Meghann Pogue, Robert D. Van Horn, Xi Rao, Denis McCann, Andrew J. Dropsey, Jason Manro, Jennie Walgren, Eunice Yuen, Michael J. Rodriguez, Gregory D. Plowman, Ramon V. Tiu, Sajan Joseph, Sheng-Bin Peng
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2020) 19 (2): 325–336.
https://doi.org/10.1158/1535-7163.MCT-19-0183
Published: 06 February 2020
View article titled, ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine
Open the PDF for ERK Inhibitor LY3214996 Targets ERK Pathway–Driven Cancers: A Therapeutic Approach Toward Precision Medicine in another window
Includes: Supplementary data
Journal Articles

Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration

Free
Genshi Zhao, Colin F. Green, Yu-Hua Hui, Lourdes Prieto, Robert Shepard, Sucai Dong, Tao Wang, Bo Tan, Xueqian Gong, Lisa Kays, Robert L. Johnson, Wenjuan Wu, Shobha Bhattachar, Miriam Del Prado, James R. Gillig, Maria-Carmen Fernandez, Ken D. Roth, Sean Buchanan, Ming-Shang Kuo, Sandaruwan Geeganage, Timothy P. Burkholder
Journal: Molecular Cancer Therapeutics
Series: Author Choice
Mol Cancer Ther (2017) 16 (12): 2677–2688.
https://doi.org/10.1158/1535-7163.MCT-16-0674
Published: 03 December 2017
View article titled, Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration
Open the PDF for Discovery of a Highly Selective NAMPT Inhibitor That Demonstrates Robust Efficacy and Improved Retinal Toxicity with Nicotinic Acid Coadministration in another window
Includes: Supplementary data
Journal Articles

Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice

Free
Wenjuan Wu, Michael S. O'Reilly, Robert R. Langley, Rachel Z. Tsan, Cheryl H. Baker, Neby Bekele, Xi Ming Tang, Amir Onn, Isaiah J. Fidler, Roy S. Herbst
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (10): 2652–2663.
https://doi.org/10.1158/1535-7163.MCT-06-0759
Published: 15 October 2007
View article titled, Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice
Open the PDF for Expression of epidermal growth factor (EGF)/transforming growth factor-α by human lung cancer cells determines their response to EGF receptor tyrosine kinase inhibition in the lungs of mice in another window
Journal Articles

Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade

Free
Wenjuan Wu, Amir Onn, Takeshi Isobe, Satoshi Itasaka, Robert R. Langley, Tomoaki Shitani, Keiko Shibuya, Ritsuko Komaki, Anderson J. Ryan, Isaiah J. Fidler, Roy S. Herbst, Michael S. O'Reilly
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2007) 6 (2): 471–483.
https://doi.org/10.1158/1535-7163.MCT-06-0416
Published: 16 February 2007
View article titled, Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade
Open the PDF for Targeted therapy of orthotopic human lung cancer by combined vascular endothelial growth factor and epidermal growth factor receptor signaling blockade in another window